WuXi Healthcare Ventures
Description
WuXi Healthcare Ventures was established in 2011 as the venture capital arm of WuXi AppTec, a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company. Based in Cambridge, Massachusetts, the firm was dedicated to identifying and fostering innovative life science companies developing transformative therapies and technologies. Its strategic alignment with WuXi AppTec provided portfolio companies with unique access to R&D services and resources, accelerating their development pathways and offering a distinct competitive advantage.
The firm's investment strategy focused on early to growth-stage companies across a broad spectrum of healthcare sectors, including novel therapeutics, medical devices, diagnostics, and digital health. WuXi Healthcare Ventures aimed to bridge the gap between scientific discovery and clinical application, leveraging its deep industry expertise and network. The firm successfully raised two dedicated funds: WuXi Healthcare Ventures Fund I, which closed with $150 million, and WuXi Healthcare Ventures Fund II, which secured $200 million, bringing its total capital under management to $350 million.
WuXi Healthcare Ventures typically deployed first checks ranging from $5 million to $15 million, primarily targeting Series A and B financing rounds. This investment approach allowed them to support companies through critical early development milestones. Notable investments included companies like Denali Therapeutics, a biopharmaceutical company focused on neurodegenerative diseases, and Hua Medicine, a clinical-stage drug development company. These investments underscored the firm's commitment to backing ventures with high potential for significant patient impact.
In 2017, WuXi Healthcare Ventures underwent a significant evolution, merging with F-Prime Capital Partners' China fund to form 6 Dimensions Capital. This strategic consolidation created a larger, more comprehensive healthcare-focused venture capital platform with expanded global reach and increased capital. While the original WuXi Healthcare Ventures brand transitioned, its legacy of supporting groundbreaking life science innovation continues through 6 Dimensions Capital, which maintains offices in both Shanghai and Boston, continuing to invest in transformative healthcare solutions worldwide.
Investor Profile
WuXi Healthcare Ventures has backed more than 39 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 15% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, China, Israel.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Typical check size: $5M – $15M.
Stage Focus
- Series B (36%)
- Series A (33%)
- Series C (15%)
- Series D (8%)
- Series Unknown (5%)
- Series E (3%)
Country Focus
- United States (64%)
- China (33%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Israel (3%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Pharmaceutical
- Life Science
- Genetics
- Oncology
- Medical Device
- Biopharma
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
